VRDN Viridian Therapeutics, Inc. - Common Stock
$24,47
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 6, 2026
Rango 52S
$13–$34
53% of range
Calificación del Analista
BUY
23 analysts
Precio Objetivo
$37
+50% upside
P/E (TTM)
-6.1
ROE
-55.4%
Margen de Beneficio Neto
-483.6%
VRDN Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$24.46
Capitalización Bursátil
$2.51B
P/E (TTM)
-6.1
BPA (TTM)
$-5.31
Ingresos (TTM)
$71M
Rendimiento div.
—
ROE
-55.4%
Deuda/Capital
—
Rango 52S
$13 – $34
VRDN Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$71M
2016-12-31
→
2025-12-31
BPA
$-5.31
2020-12-31
→
2023-12-31
Flujo de caja libre
$-277M
2016-12-31
→
2025-12-31
Márgenes
-483.6%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
VRDN
Mediana de Pares
P/E (TTM)
-6.1
55.4
P/S (TTM) (P/V (TTM))
35.4
19.0
P/B (P/C)
3.5
5.1
Price / FCF (Precio / FCF)
-9.1
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
VRDN
Mediana de Pares
Operating Margin (Margen Operativo)
-512.9%
—
Net Profit Margin (Margen de Beneficio Neto)
-483.6%
-20.8%
ROA
-41.7%
-38.3%
ROE
-55.4%
-47.8%
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
VRDN
Mediana de Pares
Current Ratio (Ratio corriente)
12.6
8.5
Quick Ratio (Ratio Rápido)
12.4
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
VRDN
Mediana de Pares
Revenue YoY (Ingresos interanuales)
23359.9%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
242.0%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
132.2%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
VRDN
Mediana de Pares
VRDN Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
23 analistas
- Compra fuerte 8 34,8%
- Compra 14 60,9%
- Mantener 1 4,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
16 analistas · 2026-08-18
Mediana
$35.50
Ahora
$24.46
Mín
$22.00
Máx
$50.00
Objetivo mediano
$35.50
+45,1%
Objetivo medio
$36.62
+49,7%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.19%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-1.05 | $-1.05 | -0.00% |
| 31 de marzo de 2026 | $-0.90 | $-1.12 | 0.22% |
| 31 de diciembre de 2025 | $-1.08 | $-1.09 | 0.01% |
| 30 de septiembre de 2025 | $-0.34 | $-1.10 | 0.76% |
| 30 de junio de 2025 | $-1.00 | $-1.03 | 0.03% |
| 31 de marzo de 2025 | $-0.87 | $-0.99 | 0.12% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| VRDN | $3.17B | -7.7 | 23359.9% | -483.6% | -55.4% | — |
| GENB | — | — | — | — | — | — |
| PVLA | $1.30B | -28.2 | 65.3% | -1610.6% | -110.1% | — |
| AGIO | $1.59B | -3.8 | 48.0% | -764.0% | -32.2% | — |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | — |
| SRPT | $2.26B | -3.0 | 15.6% | -32.5% | -57.1% | — |
| ZBIO | $1.98B | -4.3 | 100.0% | -3777.4% | -156.8% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 16
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $71M | $302.0K | $314.0K | $2M | $3M | $1M | $4M | $8M | $4M | $3M | $3M | $6M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | $3M | $2M | $3M | |
| R&D Expense | · | · | · | · | · | · | $35M | $30M | $20M | $14M | $1M | $347.0K | |
| SG&A Expense | $95M | $61M | $95M | $35M | $26M | $13M | $12M | $11M | $11M | $7M | $8M | $7M | |
| Operating Expenses | $434M | $299M | $255M | $136M | $83M | $111M | $46M | $41M | $31M | $20M | $14M | $11M | |
| Operating Income | $-363M | $-299M | $-254M | $-134M | $-80M | $-110M | $-42M | $-33M | $-27M | $-17M | $-11M | $-7M | |
| Interest Expense | · | · | · | $500.0K | · | · | · | · | · | $95.0K | $141.0K | $1M | |
| Interest Income | $27M | $32M | $18M | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $21M | $29M | $17M | $4M | $315.0K | $173.0K | $941.0K | · | · | · | · | · | |
| Income Tax | $0 | · | · | · | · | · | · | · | · | · | · | $0 | |
| Net Income | $-343M | $-270M | $-238M | $-130M | $-79M | $-111M | $-42M | $-33M | $-27M | $-17M | $-11M | $-8M | |
| EPS (Basic) | · | · | $-5.31 | $-4.05 | $-6.66 | $-31.13 | · | · | · | · | · | · | |
| EPS (Diluted) | · | · | $-5.31 | $-4.05 | $-6.66 | $-31.13 | · | · | · | · | · | · | |
| Shares (Basic) | · | · | 44,755,475 | 32,087,293 | 11,918,712 | 3,557,065 | · | · | · | · | · | · | |
| Shares (Diluted) | · | · | 44,755,475 | 32,087,293 | 11,918,712 | 3,557,065 | · | · | · | · | · | · | |
| EBITDA | $-363M | $-298M | $-254M | $-134M | $-80M | $-110M | $-42M | $-33M | · | $-12M | · | $-7M |
Balance general 28
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $875M | $718M | $477M | $425M | $197M | $128M | $27M | $33M | $47M | $22M | $21M | $5M | |
| Short-term Investments | · | · | · | · | $155M | $82M | $2M | $30M | $0 | · | · | · | |
| Receivables | · | · | · | · | · | · | $108.0K | $24.0K | $1M | $20.0K | $394.0K | $1M | |
| Inventory | · | · | · | · | · | · | · | · | · | $64.0K | $187.0K | $179.0K | |
| Prepaid Expense | $20M | $21M | $9M | $7M | $3M | $2M | $3M | $3M | $3M | $2M | $321.0K | $399.0K | |
| Current Assets | $894M | $738M | $486M | $431M | $200M | $130M | $30M | $65M | $52M | $24M | $12M | $7M | |
| PP&E (Net) | $1M | $1M | $2M | $1M | $375.0K | $309.0K | $523.0K | $727.0K | $563.0K | $625.0K | $1M | $1M | |
| PP&E (Gross) | $2M | $3M | $3M | $3M | $2M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | $1M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $739.0K | $555.0K | |
| Intangibles | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $2M | $501.0K | $604.0K | $982.0K | $1M | $1.0K | $0 | $50.0K | $50.0K | $258.0K | · | · | |
| Total Assets | $899M | $742M | $490M | $435M | $204M | $131M | $30M | $66M | $52M | $25M | $13M | $8M | |
| Accounts Payable | $9M | $2M | $2M | $14M | $2M | $670.0K | $1M | $571.0K | $906.0K | $1M | $242.0K | $255.0K | |
| Accrued Liabilities | $62M | $46M | $24M | $19M | $11M | $10M | $5M | $4M | $3M | $4M | $1M | $361.0K | |
| Short-term Debt | · | · | · | · | · | $0 | $4M | $2M | $0 | $2M | · | · | |
| Current Liabilities | $71M | $48M | $27M | $33M | $14M | $11M | $10M | $7M | $4M | $7M | $2M | $2M | |
| Capital Leases | $2M | $2M | $1M | $1M | $1M | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $2M | $2M | $989.0K | $1M | $1M | $43.0K | $0 | $66.0K | $152.0K | $0 | $24.0K | $109.0K | |
| Total Liabilities | $177M | $71M | $48M | $40M | $16M | $11M | $15M | $15M | $14M | $10M | · | · | |
| Long-term Debt | · | $21M | $20M | $5M | $0 | · | $8M | $10M | $10M | · | · | · | |
| Total Debt | · | $21M | · | · | · | $0 | $4M | $2M | · | · | · | · | |
| Common Stock | $1M | $810.0K | $540.0K | $414.0K | $239.0K | $42.0K | $23.0K | $308.0K | $226.0K | $8.0K | $7.0K | $38.0K | |
| Paid-in Capital | $1.93B | $1.48B | $961M | $741M | $412M | $218M | $184M | $177M | $132M | $5M | $28M | $13M | |
| Retained Earnings | $-1.34B | $-996M | $-726M | $-488M | $-358M | $-279M | $-168M | $-126M | $-94M | $-67M | $-18M | $-7M | |
| AOCI | $447.0K | $-10.0K | $338.0K | $-390.0K | $-157.0K | $-8.0K | $0 | $-3.0K | $0 | · | · | · | |
| Stockholders' Equity | $722M | $672M | $442M | $395M | $188M | $120M | $16M | $51M | $39M | $-62M | $-45M | $6M | |
| Liabilities + Equity | $899M | $742M | $490M | $435M | $204M | $131M | $30M | $66M | $52M | $25M | $13M | $8M | |
| Shares Outstanding | 101,826,500 | 80,994,046 | 53,986,112 | 41,305,947 | 23,924,004 | 4,231,135 | 2,324,126 | 30,839,463 | 22,568,006 | 833,744 | 601,667 | 3,782,629 |
Flujo de Efectivo 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $460.0K | $540.0K | $522.0K | $255.0K | $120.0K | $239.0K | $288.0K | $281.0K | $308.0K | $341.0K | $184.0K | $144.0K | |
| Stock-based Comp | $44M | $42M | $67M | $20M | $14M | $4M | $4M | $4M | $2M | $198.0K | $3M | $4M | |
| Restructuring | · | · | · | · | · | $300.0K | $2M | · | · | · | · | · | |
| Other Non-cash | $21M | $-5M | $-14M | $16M | $10M | $77M | $2M | $2M | · | $3M | · | $1M | |
| Operating Cash Flow | $-276M | $-232M | $-184M | $-94M | $-55M | $-30M | $-36M | $-27M | $-28M | $-15M | $-7M | $-2M | |
| CapEx | $495.0K | $511.0K | $898.0K | $797.0K | $338.0K | $42.0K | $84.0K | $445.0K | $246.0K | $250.0K | $123.0K | $266.0K | |
| Investing Cash Flow | $-38M | $-229M | $-94M | $-115M | $-74M | $-50M | $28M | $-30M | $1M | $-250.0K | $-95.0K | $-274.0K | |
| Debt Issued | $29M | $0 | $15M | $5M | · | · | · | · | · | · | · | · | |
| Net Debt Issued | $29M | $0 | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $63M | $70M | $15M | $292M | $114M | $0 | $2M | $45M | · | · | $13M | $7M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $2.0K | · | · | |
| Net Stock Activity | $63M | $454M | $125M | $292M | $114M | · | $2M | · | · | $-2.0K | · | $7M | |
| Financing Cash Flow | $427M | $458M | $226M | $322M | $125M | $101M | $70.0K | $42M | $52M | $16M | $13M | $7M | |
| Net Change in Cash | $113M | $-3M | $-53M | $113M | $-4M | $21M | $-8M | $-15M | $25M | · | · | · | |
| Free Cash Flow | $-277M | $-233M | $-185M | $-95M | $-55M | $-30M | $-36M | $-27M | · | $-7M | · | $-2M |
Rentabilidad 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -512.9% | -99018.2% | -81035.0% | -7579.2% | -2690.8% | -10512.4% | -941.0% | -394.5% | · | -374.8% | · | -105.9% | |
| Net Margin | -483.6% | -89387.1% | -75711.5% | -7329.2% | -2680.2% | -10544.3% | -938.6% | -390.0% | · | -379.8% | · | -121.7% | |
| EBITDA Margin | -512.3% | -98839.4% | -80868.8% | -7564.8% | -2686.7% | -10489.6% | -934.6% | -391.2% | · | -369.2% | · | -103.7% | |
| ROA | -41.7% | -43.8% | -51.4% | -40.7% | -47.4% | -137.1% | -86.9% | -55.1% | · | -147.7% | · | -134.2% | |
| ROE | -55.4% | -39.1% | -65.5% | -32.3% | -40.5% | -156.9% | -215.2% | -58.4% | · | 55.6% | · | 88.2% |
Liquidez y Solvencia 5
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.6 | 15.4 | 18.3 | 12.9 | 14.7 | 12.1 | 2.9 | 9.7 | · | 0.9 | · | 3.4 | |
| Quick Ratio | 12.4 | 15.0 | 17.9 | 12.7 | 25.8 | 19.6 | 2.8 | 9.3 | · | 0.8 | · | 3.1 | |
| Debt / Equity | · | 0.0 | · | · | · | 0.0 | 0.3 | 0.0 | · | · | · | · | |
| LT Debt / Equity | · | 0.0 | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | -268.6 | · | · | · | · | · | -131.7 | · | -6.7 |
Eficiencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | · | 0.4 | · | 1.1 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | 20.3 | · | 12.1 | |
| Receivables Turnover | · | · | · | · | · | · | 67.6 | 11.3 | · | 7.3 | · | 6.2 |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 23359.9% | -3.8% | -82.3% | -40.2% | 182.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 242.0% | -53.3% | -33.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 132.2% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $71M | $302.0K | $314.0K | $2M | $3M | $1M | $4M | $8M | $4M | $3M | $3M | $6M | |
| Net Income TTM | $-343M | $-270M | $-238M | $-130M | $-79M | $-111M | $-42M | $-33M | $-27M | $-17M | $-11M | $-8M | |
| Market Cap | $3.17B | $1.55B | $1.18B | $1.21B | $473M | $70M | $251M | $1.40B | · | $56M | · | $2.16B | |
| Enterprise Value | · | $856M | · | · | · | $-140M | $226M | $1.34B | · | · | · | · | |
| P/E | -7.7 | -4.7 | -4.1 | -7.2 | -3.0 | -0.5 | · | · | · | · | · | · | |
| P/S | 44.7 | 5141.2 | 3744.6 | 680.9 | 159.6 | 66.3 | 56.3 | 167.1 | · | 16.0 | · | 333.4 | |
| P/B | 4.4 | 2.3 | 2.7 | 3.1 | 2.5 | 0.6 | 15.9 | 27.3 | · | -171.1 | · | 360.8 | |
| P / Tangible Book | 4.4 | 2.3 | 2.7 | 3.1 | 2.5 | 0.6 | · | · | · | · | · | · | |
| P / Cash Flow | -11.5 | -6.7 | -6.4 | -12.9 | -8.7 | -2.3 | -7.0 | -52.2 | · | -7.7 | · | -976.9 | |
| P / FCF | -11.4 | -6.7 | -6.4 | -12.7 | -8.6 | -2.3 | -6.9 | -51.4 | · | -7.7 | · | -872.0 | |
| EV / EBITDA | · | -2.9 | · | · | · | 1.3 | -5.4 | -40.9 | · | · | · | · | |
| EV / FCF | · | -3.7 | · | · | · | 4.7 | -6.3 | -49.2 | · | · | · | · | |
| EV / Revenue | · | 2833.2 | · | · | · | -133.1 | 50.7 | 160.0 | · | · | · | · | |
| Earnings Yield | -13.0% | -21.1% | -24.4% | -13.9% | -33.7% | -189.2% | · | · | · | · | · | · |
Estado de resultados 13
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $284.0K | $141.0K | $132.0K | $71M | $75.0K | $72.0K | $72.0K | $86.0K | $72.0K | $72.0K | $72.0K | $72.0K | $98.0K | $1M | $256.0K | $216.0K | |
| SG&A Expense | $55M | $39M | $34M | $24M | $20M | $17M | $16M | $14M | $16M | $15M | $21M | $19M | $22M | $9M | $8M | $8M | |
| Operating Expenses | $127M | $116M | $123M | $111M | $107M | $94M | $88M | $84M | $72M | $56M | $51M | $59M | $73M | $31M | $30M | $26M | |
| Operating Income | $-126M | $-116M | $-123M | $-40M | $-107M | $-94M | $-87M | $-83M | $-72M | $-56M | $-51M | $-59M | $-72M | $-30M | $-30M | $-26M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | $200.0K | $200.0K | $200.0K | $200.0K | $0 | |
| Interest Income | $8M | $8M | $8M | $6M | $7M | $8M | $9M | $8M | · | · | · | · | · | · | · | · | |
| Other Non-op | $-851.0K | $11M | $2M | $5M | $6M | $7M | $8M | $7M | $7M | $7M | $4M | $4M | $4M | $880.0K | $73.0K | $196.0K | |
| Net Income | $-127M | $-105M | $-120M | $-35M | $-101M | $-87M | $-80M | $-77M | $-65M | $-49M | $-48M | $-55M | $-68M | $-29M | $-29M | $-26M | |
| EPS (Basic) | · | · | · | · | · | · | · | $-1.15 | $-1.02 | $-0.79 | $-1.09 | $-1.27 | $-1.61 | $-0.86 | $-1.06 | $-0.98 | |
| EPS (Diluted) | · | · | · | · | · | · | · | $-1.15 | $-1.02 | $-0.79 | $-1.09 | $-1.27 | $-1.61 | $-0.86 | $-1.06 | $-0.98 | |
| Shares (Basic) | · | · | · | · | · | · | · | 66,420,063 | 63,854,514 | 61,099,038 | 43,654,577 | 43,253,457 | 42,242,309 | 33,742,076 | 27,762,257 | 26,126,092 | |
| Shares (Diluted) | · | · | · | · | 81,593,463 | 81,344,134 | · | 66,420,063 | 63,854,514 | 61,099,038 | 43,654,577 | 43,253,457 | 42,242,309 | 33,742,076 | 27,762,257 | 26,126,092 | |
| EBITDA | $-126M | $-116M | · | $-40M | $-107M | $-94M | · | $-83M | $-72M | $-56M | $-51M | $-59M | $-72M | $-30M | $-30M | $-26M |
Balance general 25
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $982M | $762M | $875M | $491M | $563M | $637M | · | $753M | $571M | $613M | $313M | $334M | $374M | $431M | $161M | $175M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $145M | |
| Prepaid Expense | $25M | $23M | $20M | $11M | $15M | $21M | $21M | $14M | $10M | $14M | $11M | $12M | $9M | $6M | $4M | $3M | |
| Current Assets | $1.08B | $785M | $894M | $572M | $579M | $657M | $738M | $767M | $582M | $627M | $324M | $346M | $383M | $437M | $166M | $179M | |
| PP&E (Net) | $3M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $825.0K | $749.0K | $691.0K | |
| PP&E (Gross) | · | · | $2M | · | · | · | $3M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Intangibles | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1M | $888.0K | $2M | $2M | $506.0K | $489.0K | $501.0K | $853.0K | $659.0K | $555.0K | $1M | $1M | $982.0K | $1M | $2M | $2M | |
| Total Assets | $1.10B | $789M | $899M | $577M | $582M | $661M | $742M | $772M | $586M | $630M | $329M | $351M | $387M | $441M | $170M | $183M | |
| Accounts Payable | $9M | $13M | $9M | $10M | $9M | $4M | $2M | $6M | $3M | $3M | $4M | $4M | $8M | $12M | $4M | $3M | |
| Accrued Liabilities | $55M | $38M | $62M | $41M | $35M | $30M | $46M | $35M | $30M | $23M | $19M | $24M | $21M | $13M | $17M | $12M | |
| Current Liabilities | $64M | $52M | $71M | $51M | $53M | $34M | $48M | $41M | $37M | $26M | $23M | $29M | $30M | $25M | $21M | $14M | |
| Capital Leases | · | · | $2M | $2M | $2M | $2M | · | $2M | $2M | $900.0K | $1M | $1M | $1M | $800.0K | $900.0K | $1M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $896.0K | $1M | $2M | $1M | $813.0K | $938.0K | $1M | |
| Total Liabilities | $435M | $153M | $177M | $74M | $67M | $57M | $71M | $64M | $56M | $48M | $45M | $36M | $36M | $32M | $28M | $17M | |
| Long-term Debt | · | · | · | · | $21M | · | · | · | $20M | $20M | $20M | $5M | $5M | $5M | $5M | · | |
| Total Debt | · | · | · | $21M | $21M | $21M | · | $21M | $20M | · | · | · | · | · | · | · | |
| Common Stock | $1M | $1M | $1M | $822.0K | $817.0K | $816.0K | $810.0K | $792.0K | $639.0K | $638.0K | $437.0K | $436.0K | $431.0K | $402.0K | $285.0K | $272.0K | |
| Paid-in Capital | $2.13B | $1.95B | $1.93B | $1.53B | $1.51B | $1.50B | $1.48B | $1.43B | $1.17B | $1.16B | $807M | $792M | $772M | $710M | $453M | $439M | |
| Retained Earnings | $-1.57B | $-1.44B | $-1.34B | $-1.22B | $-1.18B | $-1.08B | $-996M | $-916M | $-839M | $-774M | $-659M | $-611M | $-556M | $-442M | $-413M | $-384M | |
| AOCI | $-1M | $-558.0K | $447.0K | $363.0K | $69.0K | $245.0K | $-10.0K | $932.0K | $-543.0K | $-367.0K | $-64.0K | $-173.0K | $-174.0K | $-940.0K | $-1M | $-935.0K | |
| Stockholders' Equity | $662M | $636M | $722M | $503M | $515M | $604M | $672M | $707M | $529M | $583M | $284M | $316M | $351M | $409M | $142M | $167M | |
| Liabilities + Equity | $1.10B | $789M | $899M | $577M | $582M | $661M | $742M | $772M | $586M | $630M | $329M | $351M | $387M | $441M | $170M | $183M | |
| Shares Outstanding | 113,238,218 | 102,458,094 | 101,826,500 | 82,229,158 | 81,651,186 | 81,589,427 | 80,994,046 | 79,181,445 | 63,879,675 | 63,798,536 | 43,700,989 | 43,562,208 | 43,055,318 | 40,244,355 | 28,463,980 | 23,924,004 |
Flujo de Efectivo 12
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $117.0K | $121.0K | $120.0K | $110.0K | $113.0K | $117.0K | $123.0K | $130.0K | $142.0K | $145.0K | $135.0K | $132.0K | $105.0K | $62.0K | $57.0K | $40.0K | |
| Stock-based Comp | $17M | $13M | $12M | $11M | $11M | $10M | $9M | $9M | $12M | $13M | $14M | $12M | $15M | $5M | $5M | $5M | |
| Other Non-cash | · | $-28M | · | · | · | $-16M | · | · | · | $-10M | · | · | $-9M | · | · | $-48.0K | |
| Operating Cash Flow | $-105M | $-120M | $-24M | $-85M | $-75M | $-93M | $-73M | $-68M | $-46M | $-45M | $-39M | $-45M | $-62M | $-21M | $-18M | $-21M | |
| CapEx | $1M | $23.0K | $240.0K | $127.0K | $42.0K | $86.0K | $114.0K | $293.0K | $104.0K | $0 | $404.0K | $331.0K | $115.0K | $95.0K | $292.0K | $179.0K | |
| Investing Cash Flow | $-231M | $77M | $-339M | $126M | $76M | $100M | $-63M | $-85M | $62M | $-143M | $48M | $41M | $-13M | $43M | $14M | $9M | |
| Debt Issued | · | · | · | · | · | · | $0 | · | · | · | $15M | · | · | $0 | · | · | |
| Stock Issued | $0 | $0 | $48M | $10M | $1.0K | $5M | $34M | $-150M | $0 | $186M | $0 | $0 | $0 | $267M | · | · | |
| Net Stock Activity | · | $0 | · | · | · | · | · | · | · | $186M | · | · | · | · | · | · | |
| Financing Cash Flow | $325M | $6M | $406M | $11M | $764.0K | $9M | $36M | $245M | $108.0K | $177M | $15M | $3M | $8M | $291M | $5M | $738.0K | |
| Net Change in Cash | $-11M | $-36M | $43M | $52M | $1M | $17M | $-101M | $93M | $16M | $-11M | $25M | $-1M | $-67M | $313M | $435.0K | $-11M | |
| Free Cash Flow | · | $-120M | · | · | · | $-93M | · | · | · | $-45M | · | · | $-62M | · | · | $-21M |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -44460.6% | -82389.4% | · | -56.7% | -142356.0% | -130369.4% | · | -97069.8% | -100259.7% | -77634.7% | -71144.4% | -82326.4% | -73952.0% | -2492.5% | -11548.4% | -11985.6% | |
| Net Margin | -44760.2% | -74397.9% | · | -49.0% | -134313.3% | -120711.1% | · | -89173.3% | -90268.1% | -67419.4% | -66194.4% | -76476.4% | -69541.8% | -2418.8% | -11519.9% | -11894.9% | |
| EBITDA Margin | -44460.6% | -82303.5% | · | -56.7% | -142356.0% | -130206.9% | · | -97069.8% | -100259.7% | -77433.3% | -71144.4% | -82326.4% | -73844.9% | -2492.5% | -11548.4% | -11967.1% | |
| ROA | -15.1% | -14.5% | · | -5.1% | -17.2% | -13.5% | · | -13.9% | -13.9% | -9.6% | -12.4% | -21.1% | -23.9% | -8.7% | -20.5% | -16.8% | |
| ROE | -21.6% | -16.9% | · | -5.7% | -19.3% | -14.6% | · | -15.5% | -15.4% | -10.4% | -13.8% | -24.1% | -26.4% | -9.4% | -24.5% | -18.9% |
Liquidez y Solvencia 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 16.9 | 15.1 | · | 11.3 | 11.0 | 19.5 | · | 18.6 | 15.8 | 24.0 | 13.9 | 12.1 | 12.9 | 17.3 | 7.8 | 12.5 | |
| Quick Ratio | 15.4 | 14.7 | · | 9.7 | 10.7 | 18.9 | · | 18.2 | 15.5 | 23.5 | 13.5 | 11.7 | 12.6 | 17.1 | 7.5 | 22.2 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | · | · | -296.4 | -362.4 | -148.9 | -147.8 | · |
Eficiencia 1
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Valoración (TTM) 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $71M | $71M | · | $71M | $305.0K | $302.0K | · | $302.0K | $288.0K | $314.0K | $1M | $2M | $2M | $2M | $2M | $3M | |
| Net Income TTM | $-367M | $-327M | · | $-299M | $-329M | $-277M | · | $-238M | $-216M | $-219M | $-200M | $-182M | $-152M | $-98M | $-87M | $-76M | |
| Market Cap | $2.08B | $2.00B | · | $1.77B | $1.14B | $1.10B | · | $1.80B | $831M | $1.12B | $670M | $1.04B | $1.10B | $825M | $329M | $442M | |
| Enterprise Value | · | · | · | $1.30B | $599M | $484M | · | $1.07B | $280M | · | · | · | · | · | · | · | |
| P/E | -4.5 | -4.8 | · | -5.3 | -3.5 | -3.3 | · | -5.6 | -3.1 | -3.7 | -3.2 | -5.0 | -5.6 | -4.9 | -2.1 | -2.5 | |
| P/S | 29.3 | 28.3 | · | 25.1 | 3742.6 | 3641.8 | · | 5964.8 | 2885.7 | 3557.7 | 466.5 | 639.3 | 620.6 | 440.2 | 186.1 | 149.2 | |
| P/B | 3.1 | 3.2 | · | 3.5 | 2.2 | 1.8 | · | 2.5 | 1.6 | 1.9 | 2.4 | 3.3 | 3.1 | 2.0 | 2.3 | 2.7 | |
| P / Tangible Book | 3.2 | 3.2 | · | 3.5 | 2.2 | 1.8 | · | 2.5 | 1.6 | 1.9 | 2.4 | 3.3 | 3.1 | 2.0 | 2.3 | 2.7 | |
| P / Cash Flow | · | -16.7 | · | · | · | -11.9 | · | · | · | -24.7 | · | · | -17.7 | · | · | -21.0 | |
| P / FCF | · | -16.7 | · | · | · | -11.9 | · | · | · | -24.7 | · | · | -17.6 | · | · | -20.8 | |
| EV / EBITDA | · | · | · | -32.6 | -5.6 | -5.2 | · | -12.8 | -3.9 | · | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -5.2 | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | 18.4 | 1963.5 | 1602.4 | · | 3538.7 | 972.7 | · | · | · | · | · | · | · | |
| Earnings Yield | -22.1% | -20.7% | · | -18.8% | -29.0% | -30.0% | · | -17.8% | -32.0% | -27.2% | -31.5% | -20.2% | -17.7% | -20.2% | -47.5% | -39.8% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $71M | $302.0K | $314.0K | $2M | $3M |
| Margen Operativo % | -512.9% | -99018.2% | -81035.0% | -7579.2% | -2690.8% |
| Beneficio neto | $-343M | $-270M | $-238M | $-130M | $-79M |
| EPS Diluido | — | — | $-5.31 | $-4.05 | $-6.66 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Deuda / Patrimonio | — | 0.0 | — | — | — |
| Ratio corriente | 12.6 | 15.4 | 18.3 | 12.9 | 14.7 |
| Ratio Rápido | 12.4 | 15.0 | 17.9 | 12.7 | 25.8 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-277M | $-233M | $-185M | $-95M | $-55M |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 229 declarantes · $2.0B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 57 (+2 vs trimestre anterior) | 51 (+5 vs trimestre anterior) | 84 (+3 vs trimestre anterior) | 53 (-9 vs trimestre anterior) | +24.7M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $251 908 361 | 13 713 030 | 12,33% | Acciones |
| VANGUARD GROUP INC | $153 758 256 | 4 940 818 | 7,53% | Acciones |
| Paradigm Biocapital Advisors LP | $123 515 986 | 6 723 788 | 6,05% | Acciones |
| Kynam Capital Management, LP | $118 557 720 | 6 453 877 | 5,80% | Acciones |
| STATE STREET CORP | $112 515 809 | 6 124 976 | 5,51% | Acciones |
| Fairmount Funds Management LLC | $93 520 347 | 5 090 928 | 4,58% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $84 076 918 | 4 576 860 | 4,12% | Acciones |
| Deep Track Capital, LP | $65 998 634 | 3 592 740 | 3,23% | Acciones |
| Venrock Adviser, LLC | $59 847 935 | 3 257 917 | 2,93% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $50 569 432 | 2 752 827 | 2,48% | Acciones |
| Avoro Capital Advisors LLC | $45 925 000 | 2 500 000 | 2,25% | Acciones |
| BAKER BROS. ADVISORS LP | $43 776 169 | 2 383 025 | 2,14% | Acciones |
| Point72 Asset Management, L.P. | $43 044 731 | 2 343 208 | 2,11% | Acciones |
| Caligan Partners LP | $40 303 431 | 2 193 981 | 1,97% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $39 360 387 | 2 142 171 | 1,93% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $39 323 153 | 2 140 618 | 1,92% | Acciones |
| NOVO HOLDINGS A/S | $39 219 950 | 2 135 000 | 1,92% | Acciones |
| TANG CAPITAL MANAGEMENT LLC | $32 930 540 | 1 792 626 | 1,61% | Acciones |
| Fisher Asset Management, LLC | $32 163 113 | 1 750 850 | 1,57% | Acciones |
| Candriam S.C.A. | $31 340 230 | 1 707 698 | 1,53% | Acciones |
| First Turn Management, LLC | $30 677 900 | 1 670 000 | 1,50% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $27 665 091 | 1 505 993 | 1,35% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $27 220 459 | 1 391 639 | 1,33% | Acciones |
| Parkman Healthcare Partners LLC | $25 306 071 | 1 377 576 | 1,24% | Acciones |
| Balyasny Asset Management L.P. | $23 511 010 | 1 279 859 | 1,15% | Acciones |
| RICE HALL JAMES & ASSOCIATES, LLC | $21 601 393 | 1 175 906 | 1,06% | Acciones |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $20 435 027 | 1 112 413 | 1,00% | Acciones |
| GOLDMAN SACHS GROUP INC | $20 398 617 | 1 110 431 | 1,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $18 592 975 | 1 012 138 | 0,91% | Acciones |
| Elmind Capital, LP | $18 093 182 | 984 931 | 0,89% | Acciones |
| BANK OF AMERICA CORP /DE/ | $16 025 401 | 872 368 | 0,78% | Acciones |
| Eversept Partners, LP | $15 268 079 | 831 142 | 0,75% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $14 972 046 | 815 027 | 0,73% | Acciones |
| Schonfeld Strategic Advisors LLC | $14 576 741 | 793 508 | 0,71% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $14 119 182 | 768 600 | 0,69% | Acciones |
| Woodline Partners LP | $12 876 066 | 700 929 | 0,63% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $12 079 892 | 657 588 | 0,59% | Acciones |
| PERCEPTIVE ADVISORS LLC | $10 690 973 | 581 980 | 0,52% | Acciones |
| BOOTHBAY FUND MANAGEMENT, LLC | $9 939 235 | 541 058 | 0,49% | Acciones |
| EMERALD ADVISERS, LLC | $9 870 715 | 537 328 | 0,48% | Acciones |
| ALGERT GLOBAL LLC | $8 858 694 | 482 237 | 0,43% | Acciones |
| Ikarian Capital, LLC | $7 807 251 | 425 000 | 0,38% | Acciones |
| Yiheng Capital Management, L.P. | $7 356 524 | 400 464 | 0,36% | Acciones |
| D. E. Shaw & Co., Inc. | $7 356 046 | 400 438 | 0,36% | Acciones |
| EMERALD MUTUAL FUND ADVISERS TRUST | $7 266 180 | 395 546 | 0,36% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $5 963 967 | 324 658 | 0,29% | Acciones |
| XTX Topco Ltd | $5 054 781 | 275 165 | 0,25% | Acciones |
| Blue Owl Capital Holdings LP | $4 776 200 | 260 000 | 0,23% | Acciones |
| Affinity Asset Advisors, LLC | $4 592 500 | 250 000 | 0,22% | Acciones |
| TD Asset Management Inc | $4 328 082 | 235 606 | 0,21% | Acciones |
| CAPITAL FUND MANAGEMENT S.A. | $3 634 467 | 197 848 | 0,18% | Acciones |
| FIRST TRUST ADVISORS LP | $3 329 268 | 181 234 | 0,16% | Acciones |
| Knott David M Jr | $3 324 970 | 181 000 | 0,16% | Acciones |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $3 312 993 | 180 348 | 0,16% | Acciones |
| Squarepoint Ops LLC | $3 250 663 | 176 955 | 0,16% | Acciones |
| Privium Fund Management B.V. | $3 187 489 | 173 516 | 0,16% | Acciones |
| HighVista Strategies LLC | $2 937 087 | 159 885 | 0,14% | Acciones |
| Swiss National Bank | $2 849 187 | 155 100 | 0,14% | Acciones |
| CITADEL ADVISORS LLC | $2 555 267 | 139 100 | 0,13% | Opción de compra |
| CITIGROUP INC | $2 483 661 | 135 202 | 0,12% | Acciones |
| F/m Investments LLC | $2 475 560 | 134 761 | 0,12% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 393 317 | 130 284 | 0,12% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $2 331 576 | 126 923 | 0,11% | Acciones |
| KVP Capital Advisors, LP | $2 296 250 | 125 000 | 0,11% | Acciones |
| Lighthouse Investment Partners, LLC | $2 204 400 | 120 000 | 0,11% | Acciones |
| RHUMBLINE ADVISERS | $2 162 997 | 117 747 | 0,11% | Acciones |
| ALPS ADVISORS INC | $2 049 578 | 111 572 | 0,10% | Acciones |
| Rafferty Asset Management, LLC | $1 997 719 | 108 749 | 0,10% | Acciones |
| J. Safra Sarasin Holding AG | $1 981 002 | 107 839 | 0,10% | Acciones |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1 862 975 | 101 414 | 0,09% | Acciones |
| NOMURA HOLDINGS INC | $1 840 674 | 100 200 | 0,09% | Opción de compra |
| DIADEMA PARTNERS LP | $1 837 000 | 100 000 | 0,09% | Acciones |
| Voleon Capital Management LP | $1 792 875 | 97 598 | 0,09% | Acciones |
| Bank of New York Mellon Corp | $1 787 052 | 97 281 | 0,09% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $1 777 408 | 96 756 | 0,09% | Acciones |
| Merck & Co., Inc. | $1 716 015 | 93 414 | 0,08% | Acciones |
| FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. | $1 692 765 | 92 148 | 0,08% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1 584 771 | 81 021 | 0,08% | Acciones |
| Caption Management, LLC | $1 580 555 | 86 040 | 0,08% | Acciones |
| BlackRock, Inc. | $1 530 625 | 83 322 | 0,07% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $1 499 525 | 81 629 | 0,07% | Acciones |
| Aquatic Capital Management LLC | $1 466 753 | 79 845 | 0,07% | Acciones |
| BARCLAYS PLC | $1 349 828 | 73 480 | 0,07% | Acciones |
| Knights of Columbus Asset Advisors LLC | $1 296 059 | 70 553 | 0,06% | Acciones |
| J. Goldman & Co LP | $1 239 975 | 67 500 | 0,06% | Opción de compra |
| Burkehill Global Management, LP | $1 194 050 | 65 000 | 0,06% | Acciones |
| TUDOR INVESTMENT CORP ET AL | $1 142 320 | 62 184 | 0,06% | Acciones |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1 117 740 | 60 846 | 0,05% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $1 008 789 | 54 915 | 0,05% | Acciones |
| PROFUND ADVISORS LLC | $1 006 180 | 54 773 | 0,05% | Acciones |
| MetLife Investment Management, LLC | $968 264 | 52 709 | 0,05% | Acciones |
| Greenland Capital Management LP | $918 500 | 50 000 | 0,04% | Acciones |
| SEVEN GRAND MANAGERS, LLC | $918 500 | 50 000 | 0,04% | Acciones |
| STATE OF WISCONSIN INVESTMENT BOARD | $912 401 | 49 668 | 0,04% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $911 152 | 49 600 | 0,04% | Opción de venta |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $856 042 | 46 600 | 0,04% | Opción de compra |
| Headlands Technologies LLC | $855 013 | 46 544 | 0,04% | Acciones |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $840 611 | 45 760 | 0,04% | Acciones |
| MORGAN STANLEY | $838 869 | 45 665 | 0,04% | Acciones |
| Quadrature Capital Ltd | $828 083 | 45 078 | 0,04% | Acciones |
Informantes de la empresa 39 insiders · 19 directivos · 24 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Stephen F. Mahoney | President and CEO | 3 de marzo de 2026 F | 33 349 | 0 | 0 | $0 |
| Scott Dunseth Myers | Chief Executive Officer | 12 de abril de 2023 P | 259 500 | 0 | 0 | $0 |
| Jonathan Violin | Chief Executive Officer | 2 de febrero de 2023 M | 480 905 | 0 | 0 | $0 |
| William Stuart Marshall | President & CEO | 12 de febrero de 2020 A | 265 646 | 0 | 0 | $0 |
| Samuel D Riccitelli | President & CEO | 31 de octubre de 2016 M | 571 370 | 0 | 0 | $0 |
| Seth Harmon | Chief Financial Officer | 3 de marzo de 2026 F | 7 850 | 0 | 0 | $0 |
| Kristian Humer | CFO and CBO | 8 de febrero de 2023 A | — | 0 | 0 | $0 |
| Jason A. Leverone | Chief Financial Officer | 18 de enero de 2021 A | 48 829 | 0 | 0 | $0 |
| Tamara A Seymour | CFO, Secretary, Treasurer | 31 de octubre de 2016 M | 106 447 | 0 | 0 | $0 |
| Thomas W. Beetham | Chief Operating Officer | 3 de marzo de 2026 F | 13 361 | 0 | 0 | $0 |
| Carrie Melvin | COO | 8 de febrero de 2023 A | — | 0 | 0 | $0 |
| Radhika Tripuraneni | Chief Medical Officer | 14 de agosto de 2026 M | 40 000 | 0 | 0 | $0 |
| Jennifer Tousignant | Chief Legal Officer | 3 de marzo de 2026 F | 3 494 | 0 | 1 | $-70 796 |
| Thomas Ciulla | Chief Medical Officer | 5 de febrero de 2024 A | — | 0 | 0 | $0 |
| Lara Meisner | Chief Legal Officer | 16 de junio de 2023 M | 29 971 | 0 | 0 | $0 |
| Barrett Katz | Chief Medical Officer | 8 de febrero de 2023 A | 0 | 0 | 0 | $0 |
| Diana Escolar | Chief Medical Officer | 12 de febrero de 2020 A | — | 0 | 0 | $0 |
| Adam Scott Levy | Chief Business Officer | 6 de febrero de 2019 A | 10 540 | 0 | 0 | $0 |
| Paul D Rubin | EVP, Research & Development | 6 de febrero de 2019 A | — | 0 | 0 | $0 |
| Sarah Gheuens | Consejero | 1 de julio de 2026 A | — | 0 | 0 | $0 |
| Tomas Kiselak | Consejero | 1 de julio de 2026 A | — | 0 | 0 | $0 |
| Christopher W. Cain | Consejero | 1 de julio de 2026 A | — | 0 | 0 | $0 |
| Jennifer K. Moses | Consejero | 1 de julio de 2026 A | — | 0 | 0 | $0 |
| Jeffrey Robert Ajer | Consejero | 1 de julio de 2026 A | — | 0 | 0 | $0 |
| Arlene Morris | Consejero | 1 de julio de 2026 A | — | 0 | 0 | $0 |
| Peter Harwin | Consejero | 26 de junio de 2024 A | — | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Consejero | 4 de febrero de 2021 A | — | 0 | 0 | $0 |
| Joseph L Turner | Consejero | 4 de febrero de 2021 A | — | 0 | 0 | $0 |
| Thomas E. Hughes | Consejero | 21 de mayo de 2020 A | 12 827 | 0 | 0 | $0 |
| Christopher Bowden | Consejero | 21 de mayo de 2020 A | — | 0 | 0 | $0 |
| Kevin Koch | Consejero | 21 de mayo de 2020 A | — | 0 | 0 | $0 |
| Bruce Booth | Consejero | 27 de junio de 2018 A | 1 351 090 | 0 | 0 | $0 |
| John W Creecy | Consejero | 28 de junio de 2017 A | — | 0 | 0 | $0 |
| Kyle Lefkoff | Consejero | 28 de junio de 2017 A | 463 473 | 0 | 0 | $0 |
| LEBOW BENNETT S | Consejero | 13 de febrero de 2017 M | 280 600 | 0 | 0 | $0 |
| David A Gonyer | Consejero | 8 de febrero de 2017 M | 1 899 | 0 | 0 | $0 |
| Robin L Smith | Consejero | 3 de febrero de 2017 M | 1 900 | 0 | 0 | $0 |
| Douglas A Schuling | Consejero | 15 de junio de 2016 A | 10 500 | 0 | 0 | $0 |
| Lee M. Rauch | — | 18 de enero de 2021 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II GP LLC ×9 presentaciones | 13 de mayo de 2026 | 14,04% | Enmienda | Inversión pasiva | SEC |
| ATLAS VENTURE FUND VII, L.P., ATLAS VENTURE ASSOCIATES VII, L.P., ATLAS VENTURE ASSOCIATES VII, INC. ×2 presentaciones | 14 de junio de 2023 | — | Presentación inicial | — | SEC |
| / Boulder Ventures V, L.P., / BV Partners V, L.L.C., / Boulder Ventures VI, L.P., / BV Partners VI, L.L.C., / Kyle Lefkoff, / Jonathan L. Perl, / Peter A. Roshko | 16 de agosto de 2017 | — | Presentación inicial | — | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 7 de marzo de 2017 | — | Presentación inicial | M&A / venta | SEC |
| Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada, Persona informante no revelada | 24 de febrero de 2017 | — | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 51 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| LFSC · RBB Fund, Inc. | 2,24% | 133 261 NS | 31 de mayo de 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,34% | 31 100 NS | 31 de mayo de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,40% | 152 815 NS | 30 de abril de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,31% | 8 542 NS | 30 de abril de 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,28% | 2 323 NS | 30 de abril de 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,15% | 119 401 NS | 30 de abril de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 31 418 NS | 30 de abril de 2026 | N-PORT |
| FFSM · FIDELITY COVINGTON TRUST | 0,06% | 53 991 NS | 30 de abril de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,05% | 3 045 NS | 30 de abril de 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,04% | 35 396 NS | 30 de abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,04% | 3 829 NS | 31 de mayo de 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 35 219 NS | 30 de abril de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 410 333 NS | 31 de mayo de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,03% | 11 133 NS | 30 de abril de 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 15 272 NS | 31 de mayo de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,02% | 247 665 NS | 30 de abril de 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2 995 NS | 31 de mayo de 2026 | N-PORT |
| URTY · ProShares Trust | 0,02% | 3 030 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 30 128 NS | 30 de abril de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 13 244 NS | 30 de abril de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 3 310 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 76 NS | 31 de mayo de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 30 258 NS | 31 de mayo de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1 200 NS | 30 de abril de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 8 630 NS | 30 de abril de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 122 818 NS | 30 de abril de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 24 262 NS | 30 de abril de 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 48 467 NS | 31 de mayo de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 24 895 NS | 30 de abril de 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,00% | 123 NS | 31 de mayo de 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | -0,02% | -28 615 NS | 30 de abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de julio de 2026 | Diario |
| ITOT · iShares Trust | — | — | 22 de julio de 2026 | Diario |
| IWV · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWN · iShares Trust | — | — | 17 de agosto de 2026 | Diario |
| IWO · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWM · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| IWC · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | — | — | 13 de julio de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | — | — | 20 de julio de 2026 | Diario |
| ISCB · iShares Trust | — | — | 20 de julio de 2026 | Diario |
| ISCG · iShares Trust | — | — | 21 de julio de 2026 | Diario |
| ISCV · iShares Trust | — | — | 20 de julio de 2026 | Diario |
| SMMV · iShares Trust | — | — | 18 de agosto de 2026 | Diario |
| ESML · iShares Trust | — | — | 14 de agosto de 2026 | Diario |